-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
60 Degrees Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2022 to Q3 2025.
- 60 Degrees Pharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2025 was $538K, a 381% increase year-over-year.
- 60 Degrees Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending September 30, 2025 was $779K, a 88.7% increase year-over-year.
- 60 Degrees Pharmaceuticals, Inc. annual Cost of Revenue for 2024 was $385K, a 18.9% decline from 2023.
- 60 Degrees Pharmaceuticals, Inc. annual Cost of Revenue for 2023 was $475K, a 9.76% increase from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)